
New acquisition in Serbian pharma – Italians buy two Belgrade-based distributors for EUR 7 million in total
Svas Biosana acquired Hermes Pharma through its wholly-owned subsidiary Mark Medical for a consideration of 3.5 million euro (USD 3.8 million) plus a variable earn-out of about 250,000 euro, the company said in a press release earlier this month, reports …